Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ACR’s Response to Proposed Physician Medicare Cuts Garners National Media Attention

From the College  |  September 20, 2025

Carol A. Langford, MD, MHS

Dr. Langford

Carol Langford, MD, MHS, president of the ACR, is again making headlines as a leading voice in the fight against proposed Medicare reimbursement cuts that threaten the sustainability of rheumatology practices and patient access to care.

In recent coverage by Healthcare Dive (Sept. 16), Dr. Langford joined other physician leaders in criticizing the Centers for Medicare & Medicaid Services’ (CMS) proposed 2026 Medicare Physician Fee Schedule. Dr. Langford emphasized that the proposed changes “add to the financial burden many practices are already facing” and called for meaningful reform to ensure long-term viability for providers.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Further amplifying this message, Dr. Langford was quoted in Inside Health Policy (Sept.15; subscriber-only), where she outlined the ACR’s formal response to the CMS. The ACR’s comment letter covers several concerns, including:

  • Nominal Conversion Factor (CF) Increase: Although the CMS proposes a slight boost, inflation-adjusted Medicare payments have dropped 33% since 2001.
  • Code Valuation Changes: A proposed -2.5% efficiency adjustment could undermine access to cognitive specialists, including rheumatologists.
  • Telehealth Flexibilities: The ACR applauds the CMS’s efforts to expand telehealth but urges Congress to make these flexibilities permanent.
  • Part B Drug Reimbursement: Proposed changes to drug pricing calculations could force small practices to operate at a loss, threatening patient access to care.
  • Biosimilar Drug Rebates: Current rebate structures may result in “underwater payments,” placing additional financial strain on providers.

Dr. Langford’s statement in Inside Health Policy captures the urgency of the moment:

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Sooner or later, policymakers must address our outdated and unsustainable Medicare Physician payment system, but unfortunately, this proposed rule doesn’t do it. … Expanded telehealth services have been a positive game-changer for many patients with rheumatic disease. … The time to protect practice sustainability and patient access to high-quality care is now.”

As the healthcare community awaits the CMS’s final rule, Dr. Langford and the ACR continue to advocate for reforms that prioritize both provider sustainability and patient well-being.

Share: 

Filed under:Legislation & Advocacy Tagged with:Medicare Physician Fee Schedule (MPFS)

Related Articles

    The Doctor Will See You Now: Legal & Regulatory Reforms Expand Telemedicine

    March 17, 2020

    In this time of COVID-19, you may be considering ways to deliver routine rheumatologic care via some form of telemedicine. Here are some of the legal considerations.

    Telerheumatology: What’s Next?

    December 17, 2020

    In an ACR Convergence session, two rheumatologists discussed how COVID-19 changed the use of telemedicine, how payers reacted and which changes are likely permanent and which are likely to be temporary.

    Reimbursement Tips: Telemedicine & Coding in the Time of COVID-19

    April 24, 2020

    Humans may fear change as a general rule, but we’re adaptable when we need to be. In this era of COVID-19 and social distancing, medical practices and payers are adapting to an increased use of telemedicine, which enables providers to see their patients without being in a room with them. To cope, the Centers for…

    What’s Next for Telehealth after the COVID-19 Public Health Emergency?

    June 10, 2023

    Do you remember where you were when the COVID-19 Public Health Emergency (PHE) was declared on Jan. 31, 2020? While it may seem like yesterday, you would be forgiven for not recalling your exact location over three years ago during what felt like an incredible whirlwind for the healthcare industry. One possible location you may…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences